Newsletter
HFX for PDN: A Nondrug Solution for Painful Diabetic Neuropathy with Niamh Pellegrini and Meredith Vornholt of Nevro

Outcomes Rocket

HFX for PDN: A Nondrug Solution for Painful Diabetic Neuropathy with Niamh Pellegrini and Meredith Vornholt of Nevro

April 25, 2022

HFX for PDN: A Nondrug Solution for Painful Diabetic Neuropathy with Niamh Pellegrini and Meredith Vornholt of Nevro

In this episode, we are privileged to host two outstanding healthcare leaders who can help us learn a new way of managing painful diabetic neuropathy. Niamh Pellegrini is the Chief Commercial Officer at Nevro, and Meredith Vornholt is the Senior Director.

Niamh and Meredith discuss HFX for PDN and how it can help patients suffering from painful diabetic neuropathy. They share insights on leveraging technology to help patient care, employer impact, challenges, patient anecdotes, and much more.

HFX for PDN is the only spinal cord stimulation device approved by the FDA with a specific indication to treat PDN.

Learn more about this innovative treatment in this exciting episode of the Outcomes Rocket podcast, so please tune in!

Click this link to the show notes, transcript, and resources: outcomesrocket.health

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
Reading, Writing and Anxiety When pediatric mental health collides with the US healthcare system.